Dalton Pharma Services enters into a drug development and manufacturing services agreement with ExCellThera Inc.
Posted on November 22nd, 2018
Dalton Pharma Services, a leading North American pharmaceutical cGMP CDMO, is pleased to announce its drug development and manufacturing services agreement with ExCellThera Inc, an innovative biotechnology company focused on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use. This agreement provides ExCellThera access to Dalton`s State-of-the-Art cGMP, Health Canada approved biopharmaceutical facility in Toronto, ON, Canada. Under the agreement terms… PRWeb, November 22, 2018